Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?

Abstract

Crohn’s disease (CD) and ulcerative colitis (UC), known as inflammatory bowel disease (IBD), are fairly common chronic inflammatory conditions of the gastrointestinal tract. Although the exact etiology of IBD remains uncertain, dysfunctional immunoregulation of the gut is believed to be the main culprit. Amongst the immunoregulatory factors, reactive oxygen species are produced in abnormally high levels in IBD. Their destructive effects may contribute to the initiation and/or propagation of the disease. We provided an extensive overview on the evidences from animal and human literature linking oxidative stress to IBD and its activity. Moreover, the effects of antioxidant therapy on IBD patients in randomized, controlled trials were reviewed and the need for further studies elaborated. We also summarized the evidence in support for causality of oxidative stress in IBD.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Brandtzaeg P, Haraldsen G, Rugtveit J (1997) Immunopathology of human inflammatory bowel disease. Semin Immunopathol 18(4):555–589

    Article  CAS  Google Scholar 

  2. 2.

    Spitz DR, et al. (2004) Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23(3–4):311–322

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Mueller S (2000) Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems. Free Radic Biol Med 29(5):410–415

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Togashi H, et al. (2000) Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med 28(6):846–853

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Faulkner K, Fridovich I (1993) Luminol and lucigenin as detectors for O2. Free Radic Biol Med 15(4):447–451

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Briggs RT, et al. (1986) Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84(4–6):371–378

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Pick E, Keisari Y (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38(1–2):161–170

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142(2):231–255

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Collins AR, Horvathova E (2001) Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem Soc Trans 29(Pt 2):337–341

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Dalle-Donne I, et al. (2003) Protein carbonylation in human diseases. Trends Mol Med 9(4):169–176

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Hoffmann JC, et al. (2002) Animal models of inflammatory bowel disease: an overview. Pathobiology 70(3):121–130

    PubMed  Article  Google Scholar 

  12. 12.

    Esworthy RS, et al. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281(3):G848–855

    PubMed  CAS  Google Scholar 

  13. 13.

    Forrest CM, et al. (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527:395–400

    PubMed  CAS  Google Scholar 

  14. 14.

    Geerling BJ, et al. (1999) The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn’s disease and controls. Scand J Gastroenterol 34(11):1108–1116

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Genser D, et al. (1999) Status of lipidsoluble antioxidants and TRAP in patients with Crohn’s disease and healthy controls. Eur J Clin Nutr 53(9):675–679

    PubMed  Article  CAS  Google Scholar 

  16. 16.

    Koutroubakis IE, et al. (2004) Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49(9):1433–1437

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Wendland BE, et al. (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn’s disease. Am J Clin Nutr 74(2):259–264

    PubMed  CAS  Google Scholar 

  18. 18.

    Erichsen K, et al. (2003) Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn’s disease. Scand J Gastroenterol 38(5):543–548

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Holmes EW, et al. (1998) Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 43(5):1088–1095

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Rezaie A, Eshghtork A, Zamani M, Dehghan G, Taghavi B, Nikfar S, Daryani N, Abdollahi M. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta1 in relation to disease activity in Crohn’s disease patients. Ann N Y Acad Sci (in press)

  21. 21.

    Miles AM, Grisham MB (1994) Antioxidant properties of aminosalicylates. Methods Enzymol 234:555–572

    PubMed  CAS  Article  Google Scholar 

  22. 22.

    Aghdassi E, et al. (2003) Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 98(2):348–353

    PubMed  CAS  Google Scholar 

  23. 23.

    Trebble TM, et al. (2005) High-dose fish oil and antioxidants in Crohn’s disease and the response of bone turnover: a randomised controlled trial. Br J Nutr 94(2): 253–261

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Trebble TM, et al. (2004) Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 80(5):1137–1144

    PubMed  CAS  Google Scholar 

  25. 25.

    Geerling BJ, et al. (2000) Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6(2):77–84

    PubMed  CAS  Article  Google Scholar 

  26. 26.

    Seidner DL, et al. (2005) An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3(4):358–369

    PubMed  Article  CAS  Google Scholar 

  27. 27.

    Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94

    PubMed  Article  Google Scholar 

  28. 28.

    Meyer CT, et al. (1981) Hydrogen peroxide colitis: a report of three patients. J Clin Gastroenterol 3(1):31–35

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Bilotta JJ, Waye JD (1989) Hydrogen peroxide enteritis: the “snow white” sign. Gastrointest Endosc 35(5):428–430

    PubMed  CAS  Article  Google Scholar 

  30. 30.

    Riedle B, Kerjaschki D (1997) Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 151(1):215–231

    PubMed  CAS  Google Scholar 

  31. 31.

    Rao RK, et al. (1997) Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 273(4 Pt 1):G812–G823

    PubMed  CAS  Google Scholar 

  32. 32.

    Fries W, et al. (2005) Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn’s disease in Southern Italy. Am J Gastroenterol 100(12):2730–2736

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Buhner S, et al. (2006) Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 55(3):342–347

    PubMed  Article  CAS  Google Scholar 

  34. 34.

    Ding X, et al. (2005) Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci 96(3):157–163

    PubMed  Article  CAS  Google Scholar 

  35. 35.

    Tham DM, Whitin JC, Cohen HJ (2002) Increased expression of extracellular glutathione peroxidase in mice with dextran sodium sulfate-induced experimental colitis. Pediatr Res 51(5):641–646

    PubMed  CAS  Google Scholar 

  36. 36.

    Ardite E, et al. (2000) Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 80(5):735–744

    PubMed  CAS  Google Scholar 

  37. 37.

    Nieto N, et al. (2000) Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 45(9):1820–1827

    PubMed  Article  CAS  Google Scholar 

  38. 38.

    Ghazanfari GMB, Yasa N, Ashtaral-Nakhai L, Mohammadirad A, Nikfar S, Dehghan G, Shetab-Boushehri V, Jamshidi H, Khorasani R, Salehnia A, Abdollahi M (2006) Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicology Mechanisms Methods 16(7):365–372

    Article  CAS  PubMed  Google Scholar 

  39. 39.

    Ghafari HYN, Mohammadirad A, Dehghan G, Zamani MJ, Nikfar S, Khorasani S, Minaie B, Abdollahi M (2006 Jun) Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Human Experimental Toxicol 25:325–332

    Article  CAS  Google Scholar 

  40. 40.

    Jahanshahi G, et al. (2004) Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49(11–12):1752–1757

    PubMed  Article  CAS  Google Scholar 

  41. 41.

    Barbosa DS, et al. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19(10):837–842

    PubMed  Article  CAS  Google Scholar 

  42. 42.

    Kruidenier L, et al. (2003) Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201(1):28–36

    PubMed  Article  CAS  Google Scholar 

  43. 43.

    Tuzun A, et al. (2002) Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35(7):569–572

    PubMed  Article  CAS  Google Scholar 

  44. 44.

    Sampietro GM, et al. (2002) Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn’s disease. Dig Liver Dis 34(10):696–701

    PubMed  Article  CAS  Google Scholar 

  45. 45.

    D’Odorico A, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36(12):1289–1294

    PubMed  Article  CAS  Google Scholar 

  46. 46.

    Levy E, et al. (2000) Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn’s disease. Am J Clin Nutr 71(3):807–815

    PubMed  CAS  Google Scholar 

  47. 47.

    Chiarpotto E, et al. (1997) Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic Biol Med 22(5):889–894

    PubMed  Article  CAS  Google Scholar 

  48. 48.

    Lih-Brody L, et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41(10):2078–2086

    PubMed  Article  CAS  Google Scholar 

  49. 49.

    Cao W, et al. (2004) Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 286(5):G833–G843

    PubMed  Article  CAS  Google Scholar 

  50. 50.

    Pelli MA, et al. (1999) Breath alkanes determination in ulcerative colitis and Crohn’s disease. Dis Colon Rectum 42(1):71–76

    PubMed  Article  CAS  Google Scholar 

  51. 51.

    Hatoum OA, et al. (2003) Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125(1):58–69

    PubMed  Article  CAS  Google Scholar 

  52. 52.

    Koch TR, et al. (2000) Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 45(9):1814–1819

    PubMed  Article  CAS  Google Scholar 

  53. 53.

    Tsunada S, et al. (2003) Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol 38(9):1002–1003

    PubMed  Article  CAS  Google Scholar 

  54. 54.

    Kruidenier L, et al. (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201(1):17–27

    PubMed  Article  CAS  Google Scholar 

  55. 55.

    Szanto I, et al. (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207(2):164–176

    PubMed  Article  CAS  Google Scholar 

  56. 56.

    Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 19(6):911–918

    PubMed  Article  CAS  Google Scholar 

  57. 57.

    Reimund JM, et al. (2000) Antioxidant and immune status in active Crohn’s disease: a possible relationship. Clin Nutr 19(1):43–48

    PubMed  Article  CAS  Google Scholar 

  58. 58.

    Hoffenberg EJ, et al. (1997) Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr 65(5):1482–1488

    PubMed  CAS  Google Scholar 

  59. 59.

    Fernandez-Banares F, et al. (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84(7):744–748

    PubMed  CAS  Google Scholar 

  60. 60.

    Kuroki F, et al. (1993) Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig Dis Sci 38(9):1614–1618

    PubMed  Article  CAS  Google Scholar 

  61. 61.

    Hinks LJ, et al. (1988) Reduced concentrations of selenium in mild Crohn’s disease. J Clin Pathol 41(2):198–201

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mohammad Abdollahi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rezaie, A., Parker, R.D. & Abdollahi, M. Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?. Dig Dis Sci 52, 2015–2021 (2007). https://doi.org/10.1007/s10620-006-9622-2

Download citation

Keywords

  • Animal
  • Crohn’s disease
  • Human
  • Inflammatory bowel disease
  • Oxidative stress
  • Ulcerative colitis